the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through
intravenous infusion，in order to improved the quality of block in regional anesthesia. In
this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed
with ropivacaine in coracoid approach brachial plexus block.